sábado, 22 de junio de 2019

VA declines broad coverage for new J&J depression drug touted by Trump

VA declines broad coverage for new J&J depression drug touted by Trump

Daily Recap

VA declines broad coverage for new J&J depression drug touted by Trump

By LEV FACHER AND ED SILVERMAN


STAT
Many experts have embraced the medication, known as esketamine, but some watchdog groups have expressed concerns about its effectiveness and safety.

No hay comentarios: